IGF-1 receptor signalling determines the mitogenic potency of insulin analogues in human smooth muscle cells and fibroblasts. (Q53525094)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898992%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

IGF-1 receptor signalling determines the mitogenic potency of insulin analogues in human smooth muscle cells and fibroblasts (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898992%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898992%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

C May

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898992%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

M Koenen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898992%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

J Eckel

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898992%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

18 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898992%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898992%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898992%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898992%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

2534-2543

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17898992%20AND%20SRC:MED&resulttype=core&format=json

Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells

8 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-007-0815-9

Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-007-0815-9

Insulin and its analogue glargine do not affect viability and proliferation of human coronary artery endothelial and smooth muscle cells

21 January 2018

1 reference

12 December 2020

Effects of the rapid-acting insulin analog glulisine on cultured human skeletal muscle cells: comparisons with insulin and insulin-like growth factor I.

1 reference

12 December 2020

Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor

1 reference

12 December 2020

A novel insulin analog with unique properties: LysB3,GluB29 insulin induces prominent activation of insulin receptor substrate 2, but marginal phosphorylation of insulin receptor substrate 1.

1 reference

12 December 2020

Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double-blind and cross-over trial

1 reference

12 December 2020

Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin/IGF-I hybrid receptors in endothelial cells

1 reference

12 December 2020

Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects

1 reference

12 December 2020

Insulin analogues and their potential in the management of diabetes mellitus

1 reference

12 December 2020

A review of basal insulins

1 reference

12 December 2020

Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency

1 reference

12 December 2020

Improved postprandial glycaemic controls with insulin Aspart in type 2 diabetic patients treated with insulin

1 reference

12 December 2020

Initiating basal insulin therapy in patients with type 2 diabetes mellitus.

1 reference

12 December 2020

Insulin therapy-realising the potential

1 reference

12 December 2020

Post-prandial administration of the insulin analogue insulin aspart in patients with Type 1 diabetes mellitus

1 reference

12 December 2020

The long acting human insulin analog HOE 901: characteristics of insulin signalling in comparison to Asp(B10) and regular insulin

1 reference

12 December 2020

Insulin glargine: a long-acting insulin for diabetes mellitus.

1 reference

12 December 2020

Timing-dependence of insulin-receptor mitogenic versus metabolic signalling: a plausible model based on coincidence of hormone and effector binding.

1 reference

12 December 2020

Insulin glargine: long-acting basal insulin analog for improved metabolic control

1 reference

12 December 2020

Reducing hypoglycaemia with insulin analogues

1 reference

12 December 2020

Insulin-like growth factor I receptor activity in human medulloblastomas.

1 reference

12 December 2020

Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities

1 reference

12 December 2020

The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake

1 reference

12 December 2020

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

1 reference

12 December 2020

IGF-I/insulin hybrid receptors in human endothelial cells

1 reference

12 December 2020

Significance of quiescent smooth muscle migration in the injured rat carotid artery

1 reference

12 December 2020

Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II

1 reference

12 December 2020

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

1 reference

12 December 2020

Expression of IGF-I, IGF-I receptor and IGF binding proteins-1, -2, -3, -4 and -5 in human atherectomy specimens

1 reference

12 December 2020

Recombinant DNA technology in the treatment of diabetes: insulin analogs

1 reference

12 December 2020

Expression and function of receptors for insulin-like growth factor-I and insulin in human coronary artery smooth muscle cells

1 reference

12 December 2020